REQUEST A DEMO
Total
USD $0.00
Search more companies

Moleculas Farmaceuticas S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Moleculas Farmaceuticas S.A.S. Profile Updated: December 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Moleculas Farmaceuticas S.A.S. is a company in Colombia, with a head office in Medellin. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on October 25, 2018. It currently has a total number of 7 (2025) employees. The latest financial highlights indicate a net sales revenue increase of 15.26% in 2024. Over the same period, its total assets grew by 74.12%. The net profit margin of Moleculas Farmaceuticas S.A.S. increased by 1.38% in 2024.

Headquarters
Calle 50 46 36 Edificio Furatena Of 609
Medellin; Antioquia;

Contact Details: Purchase the Moleculas Farmaceuticas S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Moleculas Farmaceuticas S.A.S. report to view the information.
Financial Auditors:
Purchase the Moleculas Farmaceuticas S.A.S. report to view the information.
Incorporation Date:
October 25, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Moleculas Farmaceuticas S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
15.26%
Total operating revenue
15.26%
Operating Profit/Loss (EBIT)
0.26%
Net Profit/Loss for the Period
28.65%
Total Assets
74.12%
Total Equity
47.74%
Operating Profit Margin (ROS)
-1.71%
Net Profit Margin
1.38%
Return on Equity (ROE)
-6.81%
Quick Ratio
6.32%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?